include electrophoresis of extracts of cultured amniotic fluid cells with visual demonstration of absence of AS-A activity. Immunologic techniques applied to cell-free amniotic fluid may be of help in the rapid identification of the fetal genotypes.
Speculation
Qualitative niethods such as electrophoresis and immunodiffusion allow reliable prenatal diagnosis of metachromatic leukodystrophy using cultured amniotic fluid cells. The peculiarities of arylsulfatase in amniotic fluid render this material less suitable for prenatal diagnosis, but may provide an insight in the structural and functional defect of arylsulfatase A in this disease.
Metachromatic leukodystrophy (MLD; sulfatide lipidosis) comprises a group of inherited degenerative diseases of the nervous system, characterized by demyelination and accumulation of cerebroside sulfates (sulfatides) in nervous system tissues and visceral organs (1, 42) . Deficient activity of the lysosomal enzyme, arylsulfatase A (AS-A; EC. 3.1.6.1) can be demonstrated in this disorder using synthetic chromogenic or fluorogenic substrates (1, 32) . This reflects a deficient activity of cerebroside sulfate sulfatase (22) , which leads to accumulation of undegraded sulfatides. MLD is clinically and biochemically heterogeneous and a number of clinical types of MLD have been demonstrated, thrce of which are arbitrarily named late infantile, juvenile, and adult, on the basis of age of onset. All of these variants are transmitted as autosomal recessive traits and, in spite of the variation in clinical manifestations, have equally profound deficiencies of AS-A activity (16, 28, 32) . Recently, two cases of the late infantile form of M L D have been reported with partial deficiency of AS-A (9, 25) . In mucosulfatidosis, a neurodegenerative disease clinically similar to the late infantile type of M L D , there is additional deficiency of lysosomal arylsulfatase B (AS-B) and of arylsulfatase C (AS-C), a microsomal enzyme (23) . Finally, in another lysosomal storage disease, mucopolysaccharidosis type V1 (MPS VI; Maroteaux-Lamy syndrome), deficicncy of AS-B occurs (37) .
The structural and functional relationships among the three isozymes of arylsulfatase are only partially understood. In particular, the two lysosomal forms, AS-A and AS-B, differ in molecular weight, subunit composition, isoelectric point, and antigenic properties (13, 26, 34) . The chemical nature of the compounds stored or excreted in MLD and MPS VI (1, 37) and in vitro enzymatic studies (14, 21) strongly suggests that sulfatides are natural substrates for AS-A, and that N-acetyl galactosamine-4-sulfate residues in chondroitin and dermatan sulfate are natural substrates for AS-B. Both enzymes recognize PNCS as substrate in vitro, but the activity of AS-B towards PNCS is inhibited by sodium pyrophosphate and sodium chloride; this is the basis of an indirect assay system commonly used to mcasure AS-A activity in the presence of AS-B (5). This method has been used in the recent past for prenatal diagnosis of MLD, utilizing cultured amniotic fluid cells and cell-free amniotic fluid (8, 15, 19, 24, 3 9 , 4 1 ) . In the six cases reported, there has been a considerable and worrisome variability in the results of the quantitative assays, which might be avoided by a more direct, qualitative demonstration of AS-A activity. This report describes a prenatal diagnosis of the late infantile form of M L D based on the demonstratiofi of absent AS-A activity in cultured amniotic fluid cells by cellulose acetate gel electrophoresis (32) , and by immunologic methods (30) ; and some characteristics of a new arylsulfatase isozyme detected in cell-free amniotic fluid.
CASE HISTORY
A 2.5-year-old white female was admitted to the Buffalo Children's Hospital with the typical clinical findings of MLD. Her development had been apparently normal until approximately 1 year of age when she was first noted to have difficulty with walking. At the time of admission she had been unable to walk for about 3 months, was noted t o tremble during purposeful movements, and kept her legs extended and her toes pointed while in the prone position. Her deep tendon reflexes were decreased to absent. Initial laboratory findings were unremarkable except for a cerebrospinal fluid protein of 402 mg1100 ml. A urine specimen was positive for metachromatic granules and a sural nerve biopsy revealed the typical metachromasia. The diagnosis of MLD was confirmed using cellulose acetate gel electrophoresis of extracts of the patient's leukocytes and cultured skin fibroblasts (30, 32) ; no AS-A activity was seen. Both parents showed reduction of AS-A activity, as expected in heterozygotes (18) .
The child was the product of her parent's first pregnancy. The mother was 27 years of age at the time and the father 30. When the patient was admitted, the mother was already pregnant. ~f t e r a m r o~r i a t e counseling the parents decided to have the .. . -pregnancy monitored and amniocentesis was performed at ap~roximatelv 15 weeks of eestation. On the basis of the results of iubsequeni biochemical studies on cultured amniotic fluid cells, the parents decided to terminate the pregnancy and a female fetus of approximately 19 weeks of gestational age was delivered by hysterotomy. Tissue specimens were immediately processed for biochemical and histologic studies and the remaining tissues were frozen at -60' for further studies.
MATERIALS AND METHODS

FETAL CELLS A N D TISSUES
Amniotic fluid cells obtained by amniocentesis were cultured as previously described (12) . Control cell culture samples known to be chromosomally normal were obtained from pregnancies monitored previously for chromosomal abnormalities. Refrigerated or fresh residual cell-free amniotic fluids from these and similar cases were centrifuged at 20,000 x g for 3 0 min at 4' to remove cellular debris, and either concentrated by ultrafiltration and analyzed immediately, or stored at -20'. Fetal organs and placental tissue utilized as controls were from two normal pregnancies terminated at about 20 weeks for nonthcrapeutic reasons.
PREPARATION OF SAMPLES
Cell extracts were prepared by ultrasonic disruption of a suspension (1:5 v/v) of saline-washed cells in 0.05 M sodium acetate buffer, pH 6.5, containing 0.1 % bovine serum albumin and 1 mM p-mercaptoethanol. The lysate was incubated at 25' for 3 0 min then centrifuged at 40,000 x g for 3 0 min at 4' to precipitate and remove the microsomal AS-C. Tissue extracts were prepared by mincing in distilled water ( I :5 vlv), sonication at 4", and centrifugation as above. One-tenth volume of 0.5 M acetate buffer, pH 5.0, was added to the supernatant, followed by incubation at 25' and recentrifugation (32) . Supernatants from high speed centrifugation were used for arylsulfatase assay and electrophoresis.
ELECTROPHORESIS
Electrophoresis was performed on sheets of cellulose acetate gel ("Cellogel") (43), using 0.036 M sodium barbital-0.037 M sodium acetate-acetic acid buffer, p H 7.0, containing 1 mM Pmercaptoethanol and 0.01 % sodium azidc (32) . Prior to electrophoresis, the gels were equilibrated overnight in buffer containing 0.05% bovine serum albumin. Samples of organ or cell extracts (10-20 p1) were pipetted onto the gel as thin bands 15-20 mm long and a constant current of 10 m A , 150 V was applied for 3.5 hr at room temperature. Gels were developed with substrate solution containing 3 mg/ml of 4-methyl umbelliferyl sulfate (4-MUS). potassium salt (32) . in 0.5 M sodium acetateacetic acid buffer, p H 5.6, followed by incubation at 37' in a moist chamber. The fluorescence of the bands was enhanced by placing the gel, porous face down, in 10% formalin for 4 min and then in 0.25 M sodium carbonate-glycine buffer, pH 10, for 4 min. Fluorescent bands of enzyme activity were observed under long wave (365 nm) ultraviolet light (32) .
IMMUNOLOGIC TECHNIQUES
Antisera were raised in rabbits following standard immunization procedures (2), using as antigen AS-A Fartially purified from human term placenta. Isolation of AS-A was obtained by the autolysis-cold acetone precipitation procedure of GniotSzulzycka and Komoszynsky (11) . followed by lyophilization and preparative electrophoresis on Pevikon (44) blocks at 4' in barbital-acetate buffer as above. Absence of AS-B in the eluted AS-A was assessed by analytic electrophoresis on Cellogel. A s also shown by others (26, 33) , the anti-AS-A immune serum thus obtained did not cross-react with AS-B (3).
Immunoelectrophoresis and immunodiffusion were carried out on Cellogel (30) . After diffusion of the reactants and washing, the gels were developed for enzymatic activity as described above. Immune complexes of AS-A with anti-AS-A antibodies retain enzymatic activity with PNCS (26) and with the fluorogenic substrate, 4-MUS (3); thus, the oligospecific antiserum could be used to detect specifically AS-A immune complexes by their enzymatic activity. there was a decrease of AS-A activity, relative to AS-B, in the parents.
Electrophoretic examination of extracts of cultured amniotic fluid cells from the pregnancy at risk for MLD also showed absence of AS-A activity (Fig. 2a) . This result was confirmed by immunologic methods: immunodiffusion of extracts of cultured amniotic fluid cells with anti-human AS-A immune serum failed to show an enzymatically active arc of immune precipitate attributable to AS-A in the sample (Fig. 3) . After termination of the pregnancy, the diagnosis of MLD in the fetus was confirmed :lectrophoretically by showing absence of AS-A activity in ex-serum in immunoelectrophoresis (Fig. 5) . In the MLD amniotic racts of fetal liver (Fig. 2b) , other fetal organs and placenta fluids, however, no enzymatically active arcs of immune precipising as controls tissues from fetuses of similar gestational age. tate were formed after reaction with this antiserum (Fig. 6 ). n addition, microscopic examination of sections of brain and In contrast to the apparently normal enzyme activity of all cidney showed metachromatic granules of sulfatide in the fetal :ells.
Assay of AS-A activity in fetal organs using the conventional ?NCS assay (5) also showed a profound deficiency of AS-A in he affected fetus (Table 1) . Minimal activity was detected only n extracts of kidney and adrenal glands ( 2 . 3 4 3 % and 0.92-I .5% of controls, respectively). The relatively low AS-A activity n normal brain and kidney (Table 1) has also been noted by ~t h e r s (1, 41) .
Concentrated (20-to 30-fold), cell-free amniotic fluids were ilso examined by electrophoresis to determine whether this naterial could be used for prenatal diagnosis of MLD. Figure 4 shows the results of the electrophoresis of amniotic fluid from :he fetus with MLD, from a pregnancy in which MLD had been jiagnosed by another laboratory, and from a control. The electrophoretic pattern of arylsulfatase in affected pregnancies was qualitatively and quantitatively indistinguishable from that of lorrnal amniotic fluid; that is, in both normal and M L D fluids, the AS-A band was replaced by a band with lower anodal mobility. This enzyme form was antigenically related to AS-A since, in the normal fluids, it reacted with anti-AS-A immune MLD: metachromatic leukodystrophy; NDet.: not detectable. Unless otherwise noted (*), eachvalue is the average of two separate assays. bands using 4-MUS as substrate, duplicate assays of amniotic fluids with PNCS as substrate (5) showed a marked deficiency of "AS-A" activity in the fluids from the two MLD pregnancies as compared to four fluids from normal pregnancies (0-0.065 nmol PNCS cleaved/hr/mg protein amgainst 0.3 1-1.58 nmol/hr/mg).
No clues as to the origin of the arylsulfatase band with lower anodal mobility, apparently unique to amniotic fluid, and detected in 20 additional samples of amniotic fluid from pregnancies not at risk for MLD, could be obtained by either incubation at 37" of cell homogenates prepared in normal amniotic fluid, or by adjusting the pH of the amniotic fluid to that of cell extracts by dialysis against the appropriate buffer. These procedures did not alter the mobility of cellular AS-A or of the amniotic fluid arylsulfatase band, respectively. In addition, absence of activity after incubation of electrophoretic gels with 4-MUS at pH 7 showed that the band was not due to AS-C, which reacts readily at this pH (32) .
DISCUSSION
The first prenatal diagnosis of MLD was reported in 1970 by Nadler and Gerbie (24) . AS-A activity with PNCS was measured in cultured amniotic fluid cells from a pregnancy at risk and was found to be less than 1 0 % of that observed in cultured amniotic fluid cells from control subjects. The pregnancy was terrninatcd and the diagnosis confirmed by assay of AS-A activity in the liver of the fetus. Subsequently, five additional diagnoses have been reported (8, 15, 19, 39, 41) , four of which were based on the quantitative determination of AS-A activity in cultured amniotic fluid cells, and one (15) on assay of amniotic fluid. In each case, confirmation of the diagnosis in the aborted fetus was obtained biochemically and/or through the demonstration of increased quantities of metachromatic material and/or cerebroside sulfate in brain and other tissues.
This report describes the first prenatal detection of MLD based on electrophoresis of arylsulfatases in cultured amniotic fluid cells. Confirmation of absence of AS-A activity in these cells was also obtained by immunologic techniques, taking advantage of the observation that the formation of the antigenantibody complex does not interfere with the activity of the enzyme towards chromogenic (26) or fluorogenic substrates (3). In fact, there are data to suggest that the complex of AS-A with antibody results in apparent increased enzymatic activity with PNCS (26) . Other investigators (38) have reported the presence of a n antigenically cross-reacting, enzymatically inactive, AS-A protein in MLD, and Shapira and Nadler (33) have shown recently that this mutant enzyme does not retain any residual enzymatic activity. The detection of immune precipitates by enzymatic assay used in our work would not reveal the presence of inactive immune complexes; although it does not establish that enzymatically inactive cross-reacting material is present in the sample, it is not affected by the presence of such material.
The application to prenatal diagnosis of qualitative electrophoretic and immunologic techniques aimed at the direct demonstration of AS-A was undertaken because of widespread concern over the accuracy of the quantitative assay. The conventional assay using the chromogenic substrate, PNCS, depends on the assumption that the inhibition of AS-B activity in the presence of sodium pyrophosphate and sodium chloride (5) is complete. Under these assay conditions, residual AS-A activity in the range of 3.3-14.5% of normal control subjects has been found in various tissues (4, 28) , urine (36) , and serum (6) of patients with MLD. This measurable amount of AS-A activity is worrisome because it had been noted that AS-A activity in cultured amniotic fluid cells from normal fetuses was only 30-45 % of the mean levels observed in cultured skin fibroblasts of normal infants and adults (18) . These low levels raised the possibility that a heterozygous fetus might not be distinguishable from an affected fetus on the basis of enzyme activity observed in cultured amniotic fluid cells, and led us to use a sensitive electrophoretic method previously employed to demonstrate directly the abscnce of AS-A activity in late infantile and juvenile MLD (32) .
Furthcrmore. the concern that the "residual AS-A activity" in MLD might in fact be due to incompletely inhibited AS-B, raised by Porter et al. (29) , has recently received experimental support from the work of Shapira and Nadler (33) . who showed that the "residual AS-A activity" can be removed by immunoabsorption of AS-B. Furthcrmore, the same investigators have shown that purified AS-B retains about 3 % of its normal activity in the conventional AS-A assay using PNCS (35) . Thus, separation of AS-A and AS-B, followed by enzymatic assay, although technically more complex, appears to be more reliable than the indirect inhibition assay method.
The use of cell-free amniotic fluid can help in the diagnosis of lysosomal disorders (10, 17, 20, 27, 31) T o account for the difference in electrophoretic mobility between this band and AS-A from cultured amniotic fluid cells, fibroblasts, leukocytes, and tissues, wc propose that in amniotic fluid, active subunits of AS-A (34) may form heteropolymers with a less negatively charged moiety. In order to account for the enzymatic activity of the electrophoretic band in amniotic fluid from MLD fetuses, we propose further that the mutant AS-A subunits are somehow stabilized when combined with the moiety in the amniotic fluid, retaining activity with the artificial fluorogenic substrate. However, the antigenic site(s) of the mutant subunit may be altered, and thus not recognized by the antibody to normal AS-A. Alternatively, the structural alteration may result in the formation of inactive immune complexes.
In conclusion, it seems reasonable to recommend that if measurement of AS-A activity with radioactive sulfatide (7) is not feasible, an optimal procedure for the prenatal detection of MLD should include electrophoresis of extracts of cultured amniotic fluid cells with visual demonstration of absence of AS-A activity. In addition, it is possible that application of immunologic techniques to cell-free amniotic fluid may be of help in the rapid identification of the fetal genotypes, but additional cases will have to be examined to confirm the reliability of this approach. Finally, further study of the amniotic fluid arylsulfatase form may provide data on the nature of the arylsulfatase isozymes and of the biochemical defect in MD.
CONCLUSION
Metachromatic leukodystrophy was diagnosed by qualitative electrophoretic and immunologic methods in a fetus at risk for the disease, and the diagnosis was confirmed by electrophoretic study and quantitation of AS-A in the tissues of the aborted fetus. A new form of arylsulfatase, apparently replacing AS-A in normal amniotic fluids, was detected by electrophoresis, and PRENATAL DIAGNOSIS OF META CHROMATIC LEUKODYSTROPHY 1077 determined to be immunologically related to AS-A. This form was also present and active with 4-MUS in two amniotic fluids from fetuses with MLD. but it did not give enzymatically active imrnunoprecipitatcs with the anti-AS-A serum.
